Becton, Dickinson and Company BDX Medical Essentials — Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Becton, Dickinson and Company in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Becton, Dickinson and Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Becton, Dickinson and Company's medical essentials — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Becton, Dickinson and Company's medical essentials — revenue?
- Becton, Dickinson and Company (BDX) reported medical essentials — revenue of $1.65B in Q1 2026.
- What does medical essentials — revenue mean?
- This metric represents the total net sales generated by the Medical Essentials business segment, which focuses on high-volume, foundational medical products like needles, syringes, and sharps-disposal units. It serves as a primary indicator of the segment's market demand and revenue-generating capacity within the broader medical technology portfolio.